VivoSim Labs (VIVS) Net Margin (2011 - 2026)
VivoSim Labs (VIVS) posted Net Margin of 15211.11% for Q2 2026, down 92.85% on a QoQ basis from 7887.5% in Q1 2026, and down 752733.0% year-over-year from N/an in Q2 2025.
Powered by 
Analysis
VivoSim Labs (VIVS) Net Margin (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Net Margin for 14 years, with the latest figure at 15211.11% in Q2 2026.
- On a quarterly basis, Net Margin fell 752733.0% year-over-year to 15211.11% in Q2 2026; TTM through Jun 2026 was 9936.61%, a 149506.0% decrease from a year earlier, with the FY2026 full-year figure at 8575.57%, up 9665.0% from the prior year.
- Net Margin was 15211.11% for Q2 2026 at VivoSim Labs, down from 7887.5% in the prior quarter.
- The five-year high for Net Margin was 127.4% in Q1 2022, with the low at 72080.0% in Q4 2023.
- Average Net Margin over 5 years is 11705.72%, with a median of 8192.08% recorded in 2026.
- The sharpest annual moves came in 2023 and 2024: Net Margin plunged 6962504 bps in 2023, then surged 5771750 bps in 2024.
- Over 5 years, Net Margin stood at 2454.96% in 2022, then slumped by 2836 bps to 72080.0% in 2023, then surged by 80 bps to 14362.5% in 2024, then gained by 28 bps to 10350.0% in 2025, then plunged by 47 bps to 15211.11% in 2026.
- The last three Net Margin figures came in at 15211.11% (Q2 2026), 7887.5% (Q1 2026), and 10350.0% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.57 Bn | 40.49 Bn | 1.44 Bn | 5.52% |
| 2 | Medpace Holdings | 16.36 Bn | 15.86 Bn | 201.64 Mn | 17.16% |
| 3 | Charles River Laboratories International | 13.12 Bn | 12.92 Bn | 452.07 Mn | -0.08% |
| 4 | Icon | 12.49 Bn | 11.57 Bn | 479.29 Mn | 9.61% |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | -1.95% |
| 6 | Evotec SE | 625.08 Mn | 199.20 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 419.76 Mn | 335.22 Mn | 18.44 Mn | -231.74% |
| 8 | Champions Oncology | 70.27 Mn | 70.27 Mn | 7.03 Mn | -4.82% |
| 9 | MindWalk Holdings | 60.37 Mn | 52.09 Mn | 1.82 Mn | -83.13% |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | -15,211.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,211.11% |
| Mar 31, 2026 | -7,887.50% |
| Dec 31, 2025 | -10,350.00% |
| Sep 30, 2025 | -9,089.29% |
| Jun 30, 2025 | -7,683.78% |
| Mar 31, 2025 | -6,172.55% |
| Dec 31, 2024 | -14,362.50% |
| Sep 30, 2024 | -8,496.67% |
| Jun 30, 2024 | -8,574.36% |
| Mar 31, 2024 | -10,500.00% |
| Dec 31, 2023 | -72,080.00% |
| Jun 30, 2023 | -5,386.67% |
| Mar 31, 2023 | -4,692.59% |
| Dec 31, 2022 | -2,454.96% |
| Sep 30, 2022 | -4,222.08% |
| Mar 31, 2022 | -127.40% |
| Dec 31, 2019 | -1,713.76% |
| Sep 30, 2019 | -540.33% |
| Jun 30, 2019 | -946.71% |
| Mar 31, 2019 | -1,026.91% |